Literature DB >> 34762141

Safety and Efficacy of Tranexamic Acid to Minimise Perioperative Bleeding in Hepatic Surgery: A Systematic Review and Meta-Analysis.

Amanda Koh1, Alfred Adiamah1, Dhanwant Gomez1, Sudip Sanyal2.   

Abstract

INTRODUCTION: Perioperative bleeding poses a major risk during liver surgery, which can result in increased transfusion requirements, morbidity, and mortality. Tranexamic acid (TXA) effectively reduces perioperative bleeding and transfusion requirements in trauma patients. However, there remains a lack of evidence of its use in liver surgery. This meta-analysis of randomised controlled trials evaluated the efficacy and safety of TXA in liver resection and transplantation.
METHOD: A comprehensive search of Medline, Embase, CENTRAL and Clinicaltrials.gov databases was undertaken to identify studies from January 1947 to September 2021. The outcomes of the need for blood transfusion, thromboembolic events and mortality were extracted from the included studies. Quantitative pooling of data was based on the random effects model.
RESULTS: Six studies reporting on 429 patients were included. TXA reduced the need for perioperative blood transfusion in liver resection and transplantation (OR 0.09; 95% CI 0.01 to 0.72). More importantly, TXA did not increase the incidence of thromboembolic events (OR 2.22; 95% CI 0.47 to 10.43) and mortality (OR 0.60; 95% CI 0.13 to 2.76).
CONCLUSION: TXA safely reduces the need for blood transfusion in patients undergoing liver resection and transplantation.
© 2021. Société Internationale de Chirurgie.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34762141     DOI: 10.1007/s00268-021-06355-2

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  10 in total

1.  Exclusion criteria and adverse events in perioperative trials of tranexamic acid: a systematic review and meta-analysis.

Authors:  Jeffrey Yates; Iris Perelman; Simonne Khair; Joshua Taylor; Jacinthe Lampron; Alan Tinmouth; Elianna Saidenberg
Journal:  Transfusion       Date:  2018-12-05       Impact factor: 3.157

2.  Perioperative parenteral tranexamic acid in liver tumor resection: a prospective randomized trial toward a "blood transfusion"-free hepatectomy.

Authors:  Cheng-Chung Wu; Wai-Meng Ho; Shao-Bin Cheng; Dah-Cherng Yeh; Mei-Chin Wen; Tse-Jia Liu; Fang-Ku P'eng
Journal:  Ann Surg       Date:  2006-02       Impact factor: 12.969

3.  Patterns of care among patients undergoing hepatic resection: a query of the National Surgical Quality Improvement Program-targeted hepatectomy database.

Authors:  Gaya Spolverato; Aslam Ejaz; Yuhree Kim; Bruce L Hall; Karl Bilimoria; Mark Cohen; Clifford Ko; Henry Pitt; Timothy M Pawlik
Journal:  J Surg Res       Date:  2015-03-19       Impact factor: 2.192

Review 4.  Transfusion reactions: prevention, diagnosis, and treatment.

Authors:  Meghan Delaney; Silvano Wendel; Rachel S Bercovitz; Joan Cid; Claudia Cohn; Nancy M Dunbar; Torunn O Apelseth; Mark Popovsky; Simon J Stanworth; Alan Tinmouth; Leo Van De Watering; Jonathan H Waters; Mark Yazer; Alyssa Ziman
Journal:  Lancet       Date:  2016-04-12       Impact factor: 79.321

5.  The effect of a new potent antifibrinolytic agent, tranexamic acid.

Authors:  T Kobayashi; J Sugiura
Journal:  J Jpn Obstet Gynecol Soc       Date:  1966-07

Review 6.  Methods to decrease blood loss during liver resection: a network meta-analysis.

Authors:  Elisabetta Moggia; Benjamin Rouse; Constantinos Simillis; Tianjing Li; Jessica Vaughan; Brian R Davidson; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2016-10-31

7.  Optimally estimating the sample standard deviation from the five-number summary.

Authors:  Jiandong Shi; Dehui Luo; Hong Weng; Xian-Tao Zeng; Lu Lin; Haitao Chu; Tiejun Tong
Journal:  Res Synth Methods       Date:  2020-07-25       Impact factor: 5.273

Review 8.  Thromboprophylaxis for trauma patients.

Authors:  Luis M Barrera; Pablo Perel; Katharine Ker; Roberto Cirocchi; Eriberto Farinella; Carlos Hernando Morales Uribe
Journal:  Cochrane Database Syst Rev       Date:  2013-03-28

9.  Continuous small-dose tranexamic acid reduces fibrinolysis but not transfusion requirements during orthotopic liver transplantation.

Authors:  M Kaspar; M A Ramsay; A T Nguyen; M Cogswell; G Hurst; K J Ramsay
Journal:  Anesth Analg       Date:  1997-08       Impact factor: 5.108

10.  Tranexamic acid reduces red cell transfusion better than epsilon-aminocaproic acid or placebo in liver transplantation.

Authors:  A Dalmau; A Sabaté; F Acosta; L Garcia-Huete; M Koo; T Sansano; A Rafecas; J Figueras; E Jaurrieta; P Parrilla
Journal:  Anesth Analg       Date:  2000-07       Impact factor: 5.108

  10 in total
  1 in total

1.  Prophylactic tranexamic acid to reduce blood loss and related morbidities during hysterectomy: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Ahmed Abu-Zaid; Saeed Baradwan; Ehab Badghish; Rayan AlSghan; Ahmed Ghazi; Bayan Albouq; Khalid Khadawardi; Nora F AlNaim; Latifa F AlNaim; Meshael Fodaneel; Fatimah Shakir AbuAlsaud; Mohammed Ziad Jamjoom; Abdullah Ama Almubarki; Saud Owaimer Alsehaimi; Safa Alabdrabalamir; Osama Alomar; Ismail A Al-Badawi; Hany Salem
Journal:  Obstet Gynecol Sci       Date:  2022-07-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.